Sunshine Biopharma Inc. (SBFMW) stock
SBFMWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SBFM
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/30
$0.03+0.00 (+2.00%)
Close on Oct 30, 2026Market cap $11.36MP/E –Yield –
Sunshine Biopharma profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Sunshine Biopharma's profit margin for the twelve months ending Jun 30, 2026 was -16.5%. For fiscal 2025 it was -16.5%, against -14.7% the year before. The highest annual figure on record is -14.7% in fiscal 2024.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -16.5% | −1.7 |
| FY2024 | Dec 31, 2024 | -14.7% | +4.0 |
| FY2023 | Dec 31, 2023 | -18.7% | +596.7 |
| FY2022 | Dec 31, 2022 | -615.4% | +4829.0 |
| FY2021 | Dec 31, 2021 | -5444.4% | −1545.7 |
| FY2020 | Dec 31, 2020 | -3898.7% | +3962.1 |
| FY2019 | Dec 31, 2019 | -7860.9% | +88913.6 |
| FY2015 | Dec 31, 2015 | -96774.5% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -16.9% | +1.9 |
| Q1 FY2026 | Mar 31, 2026 | -15.4% | −2.1 |
| Q4 FY2025 | Dec 31, 2025 | -25.0% | −2.5 |
| Q3 FY2025 | Sep 30, 2025 | -9.4% | +4.8 |
| Q2 FY2025 | Jun 30, 2025 | -18.8% | −13.5 |
| Q1 FY2025 | Mar 31, 2025 | -13.3% | +3.8 |
| Q4 FY2024 | Dec 31, 2024 | -22.5% | −6.2 |
| Q3 FY2024 | Sep 30, 2024 | -14.2% | −3.3 |
| Q2 FY2024 | Jun 30, 2024 | -5.3% | +10.9 |
| Q1 FY2024 | Mar 31, 2024 | -17.0% | +17.8 |
| Q4 FY2023 | Dec 31, 2023 | -16.3% | +580.5 |
| Q3 FY2023 | Sep 30, 2023 | -10.9% | +1086.2 |
| Q2 FY2023 | Jun 30, 2023 | -16.2% | +342.3 |
| Q1 FY2023 | Mar 31, 2023 | -34.8% | +973.2 |
| Q4 FY2022 | Dec 31, 2022 | -596.8% | −1380.5 |
| Q3 FY2022 | Sep 30, 2022 | -1097.1% | +6921.4 |
| Q2 FY2022 | Jun 30, 2022 | -358.5% | +5086.6 |
| Q1 FY2022 | Mar 31, 2022 | -1008.0% | +14432.4 |
| Q4 FY2021 | Dec 31, 2021 | 783.8% | +4652.6 |
| Q3 FY2021 | Sep 30, 2021 | -8018.5% | −3945.0 |
| Q2 FY2021 | Jun 30, 2021 | -5445.1% | +546.6 |
| Q1 FY2021 | Mar 31, 2021 | -15440.4% | −14591.4 |
| Q4 FY2020 | Dec 31, 2020 | -3868.9% | −111.6 |
| Q3 FY2020 | Sep 30, 2020 | -4073.4% | +707.4 |
| Q2 FY2020 | Jun 30, 2020 | -5991.7% | +17446.8 |
| Q1 FY2020 | Mar 31, 2020 | -849.0% | +97472.3 |
| Q4 FY2019 | Dec 31, 2019 | -3757.3% | −3465.9 |
| Q3 FY2019 | Sep 30, 2019 | -4780.8% | – |
| Q2 FY2019 | Jun 30, 2019 | -23438.5% | – |
| Q1 FY2019 | Mar 31, 2019 | -98321.4% | – |
| Q1 FY2018 | Mar 31, 2018 | -291.4% | – |